Brown Journal of Hospital Medicine BrownJHM
4 years 2 months ago
Idiopathic inflammatory myopathies, Camille Rasmussen #BJHM #MedEd #FOAMed #Medtwitter #Myopathy #rheumtwitter #MedStudentTwitter https://t.co/dsqwHIAqnX
Dr. John Cush RheumNow
4 years 2 months ago
Are you an Expert in Still's disease, Periodic Fevers, FMF or Autoinflammatory Dz? We will add you to our expert referral listing. DM me to get on the list! https://t.co/hCkC1Yu9Nh
Dr. John Cush RheumNow
4 years 2 months ago
Novel Anti-TNF Shines in Rheumatoid Arthritis Trial
A new way of inhibiting tumor necrosis factor (TNF) for treating rheumatoid arthritis showed strong results in a phase II/III clinical trial, researchers said.
https://t.co/fTmWeIrVD5 https://t.co/LPk2Ok2gac
Dr. John Cush RheumNow
4 years 2 months ago
Placebo Works Best in Combination
Analysis of two large clinical trial datasets shows that placebo response rates in randomised controlled trials (RCTs) of patients with rheumatoid arthritis are better when the patient continued background MTX.
https://t.co/JmNGRQWv6L https://t.co/77LdcTwCvl
Dr. John Cush RheumNow
4 years 2 months ago
New Updated GRAPPA Psoriatic Arthritis Recommendations
The GRAPPA treatment recommendations have been updated and the 2021 evidence-based guidance is rich in treatment recommendations based on the key disease "domains."
https://t.co/PkDofio1eh https://t.co/kp6UEgwonV
Dr. John Cush RheumNow
4 years 2 months ago
Video: Post Hoc Analysis of the ORAL Surveillance Study
https://t.co/PVzfYlzdQa https://t.co/0RpA3CfTEE
Dr. John Cush RheumNow
4 years 2 months ago
Gabapentin Implicated in Overdose Deaths
Recent FDA and MMWR warnings suggest that gabapentin was present in almost 10% of US overdose deaths between 2019 & 2020. The report also stated that gabapentin was the cause of the death in half of these cases.
https://t.co/ilNAd7ifdZ https://t.co/5GIcySXSDZ
Dr. John Cush RheumNow
4 years 2 months ago
No science to F/U visit scheduling. Study of 114 outpt SpA visits, 34% considered unnecessary (fewer Rx change 15 v 52%) & clinical actions (23 v 63%) visits) vs. "necessary" visits (predict by ASDAS ≥2.1 & PtGA ≥3 >80%). Remote monitoring role? https://t.co/J8TIQRb0LG https://t.co/TCSN0NaeC8
Dr. Jack Cush reviews recent news, regulatory and guideline updates from the past week on RheumNow.com. Studies on methotrexate use, COVID vaccination, Supplements and vitamins, and arthrocentesis despite anticoagulation are discussed.
A new way of inhibiting tumor necrosis factor (TNF) for treating rheumatoid arthritis showed strong results in a phase II/III clinical trial, researchers said.
Analysis of two large clinical trial datasets shows that placebo response rates in randomised controlled trials (RCTs) of patients with rheumatoid arthritis are better when the patient continued background methotrexate (MTX).
Dr. John Cush RheumNow
4 years 2 months ago
Video: Cancer after Biologic Use in Patients with a History of Prior Malignancy
https://t.co/jr37Ti7c9J https://t.co/iYCXzhXD44
Dr. John Cush RheumNow
4 years 2 months ago
Study of contoured foot orthoses vs sham shoe insoles in 1st MTP #OA pain: 87 pts completed 12 wk trial that showed no differences in 1st MTP walking pain or other 2nd outcomes. Hard orthoses are no more effective than flat sham insoles https://t.co/XAFWwpSjHm https://t.co/g5J9TbG2pQ

